Condition: Nephroblastoma · Sponsor: French Africa Pediatric Oncology Group
The study is based on results form 2 previous studies carried out by the GFAOP. The aim of this study is to evaluate the capacity of units to follow the recommendations in the protocol.
This description comes directly from the study's public registry record.
BRENDA Ms MALLON, MSC · 0033142115411 · brenda.mallon@gustaveroussy.fr
Always discuss trial participation with your own doctor first.
| Centre Hospitalier Universitaire Pédiatrique Charles De Gaulle | Ouagadougou, Burkina Faso | Recruiting |
| CHU de Treichville à ABIDJAN | Abidjan, Abidjan Autonomous District, Côte d’Ivoire | Recruiting |
| CUK (Cliniques Universitaires de Kinshasa) | Kinshasa, Democratic Republic of the Congo | Recruiting |
| Cliniques Universitaires de Lubumbashi (CUL) | Lubumbashi, Democratic Republic of the Congo | Recruiting |
| HJRA, Hôpital universitaire Joseph Ravoahangy Andrianavalona | Antananarivo, Madagascar | Recruiting |
| CHU Gabriel Touré (HGT) | Bamako, Mali | Recruiting |
| Hôpital Aristide Le Dantec, Avenue Pasteur, BP 3001 | Dakar, Dakar, Senegal | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04423484